C. Lüthi

发表

Amino acid sequence of a variant pro-form of insulin-like growth factor II.

P. Zumstein, R. Humbel, C. Lüthi, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Mutants of human insulin-like growth factor II (IGF II). Expression and characterization of truncated IGF II and of two naturally occurring variants.

B. Roth, R. Humbel, C. Lüthi, 1992, European journal of biochemistry.

A mutant of human insulin-like growth factor II (IGF II) with the processing sites of proinsulin. Expression and binding studies of processed IGF II.

R. Giger, J. Zarn, R. Humbel, 1992, European journal of biochemistry.

FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluation.

M. Scharenberg, Daniela Abgottspon, L. Pang, 2010, Journal of medicinal chemistry.

Esophageal foreign bodies in dogs: 51 cases (1992 – 1997)

R. Neiger, C. Lüthi, 2002 .

Response of renal handling of sodium (Na) and bicarbonate (HCO3-) to secretin (S) in normals and patients with cystic fibrosis (CF).

B. Hadorn, O. Oetliker, R. Hagmann, 1974, Pediatric Research.

Purification of the type I insulin-like growth factor receptor from human placenta.

P. Malý, C. Lüthi, 1986, Biochemical and biophysical research communications.

The binding sites of insulin-like growth factor I (IGF I) to type I IGF receptor and to a monoclonal antibody. Mapping by chemical modification of tyrosine residues.

P. Malý, C. Lüthi, 1988, The Journal of biological chemistry.

Mutants of human insulin-like growth factor II with altered affinities for the type 1 and type 2 insulin-like growth factor receptor.

R. Giger, B. Roth, D. Bürgisser, 1991, The Journal of biological chemistry.

Potential of the bean α‐amylase inhibitor αAI‐1 to inhibit α‐amylase activity in true bugs (Hemiptera)

Y. Li, T. Higgins, S. Naranjo, 2015 .

Mutants of human insulin-like growth factor II: expression and characterization of analogs with a substitution of TYR27 and/or a deletion of residues 62-67.

B. Roth, D. Bürgisser, R. Humbel, 1991, Biochemical and biophysical research communications.

Structural Basis for D-Amino Acid Transamination by the Pyridoxal 5′-Phosphate-dependent Catalytic Antibody 15A9*

P. Christen, B. Golinelli‐Pimpaneau, C. Lüthi, 2006, Journal of Biological Chemistry.

Characterization of affinity-purified type I insulin-like growth factor receptor from human placenta.

P. Malý, C. Lüthi, C. Lüthi, 1986, Biochemical and biophysical research communications.